金城医药(300233.SZ)：终止意向性合作事项

Core Viewpoint - The company has decided to terminate the intention to cooperate with Giskit Pharma B.V. regarding the commercialization rights of ExEm Foam in China due to lack of substantial progress in negotiations [1] Group 1: Cooperation Agreement - The company announced a cooperation framework agreement with Giskit Pharma B.V. for exclusive commercialization rights of ExEm Foam in China [1] - The cooperation framework agreement is an intention-based arrangement, and no formal cooperation agreement has been signed [1] - Negotiations for the cooperation have not progressed as expected, and key issues remain unresolved [1] Group 2: Strategic Decision - The company has conducted a careful review based on its development strategy and operational circumstances [1] - As a result of the review, the company has decided to terminate the intention to cooperate on the project [1]